📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-31 15:42
95 analysed today
FollowTelegram
95
Today
150,046
All-time analysed
43,005
Positive
6,671
Negative
91,649
Neutral
8,653
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
4 announcements match the current filters (relevance ≥ 5).
Raaj Medisafe Wins ₹17.02 Cr Order from MP Public Health Services Corp for Baby Diapers
Raaj Medisafe India Ltd has secured a Letter of Award (LOA) from Madhya Pradesh Public Health Services Corporation Limited for the supply of baby diapers. The total value of the work order is approximately ₹17.02 Crores (inclusive of GST), representing about 18.1% of its TTM revenue of ₹94 Crores. The contract entails supplying 29,88,220 baby diapers (small, 10 diapers/packet) to government hospitals across Madhya Pradesh over an 18-month execution period.
Confidence: HIGH
What changedRaaj Medisafe secured an institutional government contract worth ₹17.02 Cr for baby diapers from MP Public Health Services Corporation Limited.
Why it mattersProvides solid medium-term revenue visibility, adding ~₹17.02 Cr over 18 months (~₹11.3 Cr annualized) to the company's ₹94 Cr TTM topline and strengthening its disposable hygiene segment.
Order value: ₹17.02 Crores (inclusive of GST)Order vs TTM revenue: ~18.1%Quantity: 29,88,220 Baby Diapers (Small)Execution period: Within 18 months
📅 Short termPositive sentiment driver as the order provides healthy order book accretion relative to the company's ₹110 Cr market cap.
📈 Long termValidates the company's strategic focus on the expanding baby diaper market and institutional supply capabilities.
⚠ Risk flags
- Execution and payment cycle risks typical of government institutional supply contracts
- Raw material price volatility in polymers impacting contract profitability
Key Highlights
Received Letter of Award valued at approximately ₹17.02 Crores (inclusive of GST)
Contract scope covers supply of 29,88,220 Baby Diapers (Small) in 10-diaper packets
Execution timeline is within 18 months from the date of contract
Order size represents ~18.1% of TTM revenue (₹94 Cr) and ~21.3% of FY26 revenue (₹80.02 Cr)
👀 What to Watch
Track execution milestones and revenue recognition from this government contract over upcoming quarters, along with gross margin performance given raw material sensitivity.
86% Revenue Growth: Raaj Medisafe Q1 FY27 Revenue Hits ₹29.46 Cr, PAT Rises 35% YoY
Raaj Medisafe reported a strong start to FY27 with revenue from operations jumping 86.1% YoY to ₹29.46 Cr. Net profit for the quarter stood at ₹1.97 Cr, a 35.1% increase compared to ₹1.46 Cr in Q1 FY26, marking a sharp recovery from the loss reported in the preceding quarter (Q4 FY26). The Plastics division was the primary growth engine, with segment results nearly doubling YoY. However, the Hygiene division faced significant margin pressure, with segment profits falling by 60% despite a doubling of revenue.
Confidence: HIGH
What changedThe company has achieved a significant scale-up in its Plastics division and returned to profitability after a one-off loss in Q4 FY26 caused by high deferred tax expenses.
Why it mattersThe 86% revenue jump indicates strong market demand for its packaging products, though the sharp margin drop in the Hygiene segment suggests intense competition or raw material cost pressures in the diaper market.
Revenue (Q1 FY27): ₹29.46 CrRevenue vs TTM Revenue: 36.8%Net Profit (Q1 FY27): ₹1.97 CrYoY Revenue Growth: 86.1%Hygiene Segment Profit Margin: 3.6%
📅 Short termThe stock is likely to react positively to the strong top-line growth and the return to a positive bottom line after the previous quarter's loss.
📈 Long termWhile the Plastics division shows robust growth, the company's long-term success depends on stabilizing margins in the Hygiene segment and managing its high debt-to-equity ratio of 1.37.
⚠ Risk flags
- Significant drop in promoter holding from 73.8% to 59.1% as of June 2026
- Severe margin compression in the Hygiene division
- High Debt-to-Equity ratio of 1.37
- Raw material price volatility (HDPE/PP)
Key Highlights
Revenue from operations grew 86.1% YoY to ₹29.46 Cr, representing approximately 37% of the total TTM revenue.
Net Profit increased 35.1% YoY to ₹1.97 Cr, recovering from a ₹3.23 Cr loss in the previous quarter.
Plastics division revenue surged 81.7% YoY to ₹21.12 Cr, with segment profit rising to ₹3.51 Cr from ₹1.78 Cr.
Hygiene division revenue doubled to ₹8.51 Cr, but segment profit plummeted to ₹0.31 Cr from ₹0.77 Cr YoY.
Finance costs rose to ₹0.86 Cr from ₹0.68 Cr in the same quarter last year.
👀 What to Watch
Investors should monitor the profitability of the Hygiene segment, which is seeing high volume growth but declining margins. Additionally, track the impact of high debt (D/E 1.37) on net margins as interest costs remain elevated.
Raaj Medisafe Appoints Mr. Vipul Parakh as CFO; 28+ Years Professional Experience
Raaj Medisafe India Ltd has appointed Mr. Vipul Parakh as its Chief Financial Officer effective August 12, 2026. Mr. Parakh is a Chartered Accountant with over 28 years of experience in financial operations, budgeting, and SAP implementation across manufacturing and service sectors. This leadership addition is significant for the company, which currently manages a high debt-to-equity ratio of 1.37 and reported a net loss of 3.23 Cr in the March 2026 quarter. His expertise will be critical as the company aims to lower production costs and navigate the competitive baby diaper market.
Confidence: HIGH
What changedThe company has filled the critical Chief Financial Officer (CFO) position with a seasoned professional following a period of financial volatility and a significant drop in promoter holding.
Why it mattersFor a micro-cap company with a high debt-to-equity ratio (1.37), an experienced CFO is vital for managing liquidity, debt servicing, and implementing SAP-driven efficiencies to protect margins against raw material price volatility.
Professional Experience: 28+ yearsDebt-to-Equity Ratio: 1.37Market Capitalization: 65 CrTTM Revenue: 80 CrPromoter Holding (Jun 2026): 59.08%
📅 Short termThe appointment is unlikely to have an immediate impact on the stock price, though it provides some stability to the management structure after a weak March 2026 quarter.
📈 Long termIf the new CFO can successfully optimize the capital structure and reduce the 64 Cr debt burden, it could lead to a re-rating of the stock from its current P/E of 35.4.
⚠ Risk flags
- High debt-to-equity ratio (1.37)
- Significant recent reduction in promoter holding (14.72% drop)
- Raw material price volatility (HDPE and PP)
Key Highlights
Appointment of Mr. Vipul Parakh as CFO effective August 12, 2026.
Mr. Parakh brings over 28 years of experience in financial reporting, compliance, and strategic planning.
The company reported a TTM revenue of 80 Cr with a net profit of 1.81 Cr for FY26.
Promoter holding recently decreased from 73.8% in March 2026 to 59.08% in June 2026.
The company carries a debt of 64 Cr against a market capitalization of 65 Cr.
👀 What to Watch
Investors should monitor the upcoming quarterly results to see if the new CFO's expertise in financial planning and cost reduction translates into improved operating margins, which stood at 14.7% TTM.
CFO Resignation: Kanije Fatema Dadani Patel to Step Down Effective July 14, 2026
Raaj Medisafe India Ltd has announced the resignation of its Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), Mrs. Kanije Fatema Dadani Patel. The resignation was tendered on July 10, 2026, and will be effective from the close of business on July 14, 2026. The outgoing CFO cited the pursuit of new professional opportunities and personal reasons for her departure. The company has not yet named a successor to the role.
Confidence: HIGH
What changedThe company's Chief Financial Officer and Key Managerial Personnel (KMP) is stepping down from her position.
Why it mattersThe CFO is a critical role for financial oversight and regulatory compliance; a swift and transparent replacement process is necessary to maintain operational stability.
Resignation Date: July 10, 2026Effective Cessation Date: July 14, 2026Transition Period: 4 days
📅 Short termThe market is likely to remain neutral, though the short 4-day notice period between the announcement and the effective date is a point of note for administrative continuity.
📈 Long termLimited structural impact provided the company appoints a qualified successor in a timely manner to manage its financial strategy.
⚠ Risk flags
- Short transition period (4 days) for a Key Managerial Personnel role
Key Highlights
Resignation letter received from CFO Mrs. Kanije Fatema Dadani Patel on July 10, 2026
Effective date of cessation is July 14, 2026, after business hours
The transition period between the resignation date and the effective date is 4 days
Reason for resignation cited as new professional opportunities and personal development
👀 What to Watch
Monitor the company's upcoming announcements for the appointment of a new CFO to ensure continuity in financial reporting and internal controls.
